Saudi Arabia Biotechnology Market Overview
Market Size in 2025: USD 7,467.4 Million
Market Forecast in 2034: USD 11,964.2 Million
Market Growth Rate 2026-2034: 5.38%
According to IMARC Group's latest research publication, "Saudi Arabia Biotechnology Market Size, Share, Trends and Forecast by Product Type, Technology, Application, and Region, 2026-2034", The Saudi Arabia biotechnology market size was valued at USD 7,467.4 Million in 2025. Looking forward, IMARC Group estimates the market to reach USD 11,964.2 Million by 2034, exhibiting a CAGR of 5.38% from 2026-2034.
Download a sample PDF of this report: https://www.imarcgroup.com/saudi-arabia-biotechnology-market/requestsample
How AI and Digital Transformation is Reshaping the Future of Saudi Arabia Biotechnology Market
- AI speeds drug discovery in Saudi Arabia by analyzing massive datasets, cutting research time by up to 50%, helping local firms develop treatments faster.
- The government integrates AI into biotech via Vision 2030, funding initiatives and labs focused on AI-driven genomics to personalize healthcare for Saudis.
- Companies like Neom Biotech use AI to optimize manufacturing processes, improving yields and reducing costs in producing advanced biologics locally.
- AI-powered diagnostic tools boost early disease detection, with hospitals reporting a 40% rise in accuracy for cancer screenings using machine learning algorithms.
- AI facilitates precision agriculture biotech by allowing real-time monitoring and genetic modifications, helping Saudi farms increase crop resilience and sustainability efficiently.
Saudi Arabia Biotechnology Market Trends & Drivers:
Saudi Arabia's biotech scene is exploding thanks to Vision 2030 and the National Biotechnology Strategy, which pump billions into vaccines, biomanufacturing, and genomics to cut import reliance and spark exports. King Faisal Specialist Hospital just localized CAR T-cell production, slashing cancer treatment costs by 80% and speeding access for patients nationwide. New VC funds like GOLDTRACK's SAR 940 million and IB Ventures' SAR 175 million are fueling startups in therapeutics and agri-tech, drawing global players to Riyadh's biotech zones. It's creating real jobs—aiming for 11,000 high-skill roles—while building self-sufficiency in biologics that everyday Saudis can actually afford.
Rising healthcare demands from chronic diseases like cancer and diabetes are supercharging biotech, with new cases pushing hospitals toward precision medicine and gene therapies. The Saudi Human Genome Program maps local genetics for tailored treatments, while partnerships like NEOM with WuXi AppTec bring cutting-edge biomanufacturing online. Health apps hold over 60% market share, blending DNA sequencing and nanotech for faster diagnoses in places like Jeddah's medical hubs. On the ground, it's saving lives—farmers get drought-resistant crops too, boosting food security in arid regions without wasting water.
AI, CRISPR, and green biotech are the hot trends reshaping everything, from drug discovery to sustainable farming under the strategy's plant optimization push. Vertex Pharmaceuticals' MoU localizes gene therapy manufacturing, training locals in advanced tech, while environmental biotech tackles waste with biofuels. These innovations align with MENA hub goals, exporting solutions regionally. Companies are rolling out CRISPR for genetic disorders common here, making treatments personal and effective—think quicker recoveries for kids with rare conditions, all powered by homegrown R&D hubs.
Saudi Arabia Biotechnology Industry Segmentation:
The report has segmented the market into the following categories:
Breakup by Product Type:
- Instruments
- Reagents
- Software and Services
Breakup by Technology:
- Nanobiotechnology
- Tissue Engineering and Regeneration
- DNA Sequencing
- Cell-Based Assays
- Fermentation
- PCR Technology
- Chromatography
- Others
Breakup by Application:
- Healthcare
- Food and Agriculture
- Natural Resources and Environment
- Industrial Processing
- Bioinformatics
- Others
Breakup by Region:
- Northern and Central Region
- Western Region
- Eastern Region
- Southern Region
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
Recent News and Developments in Saudi Arabia Biotechnology Market
- 2025 August: King Faisal Specialist Hospital announces breakthrough in local CAR T-cell production, becoming the first Saudi entity to manufacture therapeutic cells locally, reducing treatment costs by 80% and accelerating access to life-saving treatments.
- 2025 July: Saudi Arabia launches National Biotechnology Strategy with USD 2.5 billion investment plan, establishing dedicated biotech parks and research centers to achieve global biotechnology leadership by 2040 under Vision 2030 framework.
- 2025 June: Strategic partnership between Saudi Ministry of Health and international biotech companies accelerates gene therapy manufacturing capabilities, with new facilities incorporating AI-powered biomanufacturing and precision medicine technologies.
Note: If you require specific details, data, or insights that are not currently included in the scope of this report, we are happy to accommodate your request. As part of our customization service, we will gather and provide the additional information you need, tailored to your specific requirements. Please let us know your exact needs, and we will ensure the report is updated accordingly to meet your expectations.
About Us:
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: [email protected]
Tel No:(D) +91 120 433 0800
United States: +1-201971-6302
Comments